Abstract:OBJECTIVE:To study the inhibitory effect of medicated serum of SLW on estrogen production and to approach on the key mechanism of SLW in inhibiting the invasion ability of endometrial cells of endometriosis.METHOD:First, the model of eutopic primary cultured endometrial cells of endometriosis and hysteromyoma in vitro was successfully established. Taking that of endometrial cells of hysteromyoma as control, the secretion level of E2 of endometrial cells in the culture media supernatant at different time point with the treatment of high, middle and low dose of SLW serum was detected by electrochemiluminescence immunoassay, the activities of matrix metalloproteinase-2, 9 (MMP-2, 9) were detected by gelatinase zymography assay, and the expression of tissue inhibitor of metalloproteinase-1, 2 (TIMP-1, 2) protein was observed by immunofluorescence. After the optimal time for SLW to inhibit invasion ability of endometrial cells was identified based on time-effect relationship, another endometrial cells were divided into six groups: hysteromyoma endometrium group, eutopic endometrium of endometriosis group, eutopic endometrium of endometriosis + middle dose of SLW serum group, eutopic endometrium of endometriosis + middle dose of SLW serum + E2 group, eutopic endometrium of endometriosis + anastrozole serum group , and eutopic endometrium of endometriosis + E2 group. The activities of MMP-2, 9 and the expression of TIMP-1, 2 protein were detected according to the optimal time point.RESULT:The secretion level of E2 of eutopic endometrium in endometriosis could be decreased by SLW, which showed the dependence of time and concentration. The result of gelatinase zymography assay and immunofluorescence respectively showed that along with the time the activities of MMP-2, 9 of eutopic endometrial cells of endometriosis were significantly higher than those of hysteromyoma at the same time point (P < 0.01). After 48 hours, with the treatment of middle dose of SLW serum, the activities of MMP-2, 9 of eutopic endometrial cells of endometriosis could be decreased (P < 0.01) while the expression of TIMP-1, 2 protein could be increased obviously (P < 0.01). The malignant invasion ability improved by SLW of eutopic endometrial cells of endometriosis was partly recruited by add-back E2 treatment. There was no significant difference in the activity of MMP-2 and the expression of TIMP-1, 2 protein between eutopic endometrium of endometriosis + middle dose of SLW serum + E2group and untreated group. The behavior of invasion of endometrial cells of endometriosis could be deteriorated treated by E2 as contrast to anastrozole, a specific aromatase inhibitor.CONCLUSION:SLW could decrease the secretion of E2 so as to inhibit the invasion of the eutopic endometrial cells of endometriosis.

Effect of 17β-estradiol on secretion of the chemokines IL-8,MIP-1α,RANTES and I-309 by endometrial stromal cells in vitro

Effect of 17#Beta#--estradiol on Secretion of the Chemokines IL--8,MIP--1#alpha#,RANTES and I--309 by Endometrial Stromal Cells in Vitro

Effects of combined 17beta-estradiol with TCDD on secretion of chemokine IL-8 and expression of its receptor CXCR1 in endometriotic focus-associated cells in co-culture.

Autocrine Production of Interleukin-34 Promotes the Development of Endometriosis Through CSF1R/JAK3/STAT6 Signaling

Serum Estradiol Levels in Controlled Ovarian Stimulation Directly Affect the Endometrium.

Altered expression of interleukin-18 in the ectopic and eutopic endometrium of women with endometriosis

Exosomes from the Uterine Cavity Mediate Immune Dysregulation via Inhibiting the JNK Signal Pathway in Endometriosis

Combination of Estrogen and Dioxin is Involved in the Pathogenesis of Endometriosis by Promoting Chemokine Secretion and Invasion of Endometrial Stromal Cells

The effect of selective cyclooxygenase-2 inhibitor Meloxicam on the endometrial stromal cell apoptosis and VEGF expression of endometriosis in vitro

Possible Involvement of Crosstalk Between Endometrial Cells and Mast Cells in the Development of Endometriosis Via CCL8/CCR1

[Roles of Regulated Upon Activation Normal T Cell Expressed and Secreted in Pathogenesis of Endometriosis].

LINC01541 Overexpression Attenuates the 17Β-Estradiol-induced Migration and Invasion Capabilities of Endometrial Stromal Cells

Interleukin-22 Secreted by Ectopic Endometrial Stromal Cells and Natural Killer Cells Promotes the Recruitment of Macrophages Through Promoting CCL2 Secretion

The High Level of RANTES in the Ectopic Milieu Recruits Macrophages and Induces Their Tolerance in Progression of Endometriosis.

Downregulation of Mir-183 Inhibits Apoptosis and Enhances the Invasive Potential of Endometrial Stromal Cells in Endometriosis.

Effect of Interleukin-1Β on Expressions of Activin A and Its Related Factors in Cultured Endometrial Stromal Cells from Patients with Endometriosis

17SS-Estradiol-induced Human Endometrial Stromal Cell Invasion is Dependent on C-Fos-mediated Matrix Metalloproteinase-9 Expression

The Expression of Microrna-221 in Endometriosis and Its Impact on Endometrial Stromal Cells

Effect of GnRH II and GnRH I on secretion of VEGF by eutopic and ectopic endometrial stromal cells of endometriosis patients

Inhibitory Effect on Estrogen Production and Its Influence on Invasive Abilityof Human Endometrial Cells of Endometriosis by Medicated Serum of SLW

Transcription characteristics of chemokine receptors in endometrium and endometrial tissues